Genetic and phenotypic architecture of metabolic syndrome-associated components in dyslipidemic and normolipidemic subjects: The GEMS Study

Atherosclerosis

Volumn 197, Issue 2, 2008, Pages 868-876

  Stirnadel, Heide ^a   Lin, Xiwu ^b   Ling, Hua ^c   Song, Kijoung ^b   Barter, Philip ^d   Kesäniemi, Y Antero ^e   Mahley, Robert ^f,g   McPherson, Ruth ^h   Waeber, Gérard ⁱ   Bersot, Thomas ^f,g   Cohen, Jonathan ^j   Grundy, Scott ^j   Mitchell, Braxton ^c   Mooser, Vincent ^b   Waterworth, Dawn ^b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b GLAXOSMITHKLINE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d HEART RESEARCH INSTITUTE   (Australia)

^e UNIVERSITY OF OULU   (Finland)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g AMERICAN HOSPITAL   (Turkey)

^h UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

ⁱ LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^j UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

more..

Author keywords

Cardiovascular diseases; Diabetes mellitus, type 2; Hyperlipidemia; Lipoproteins; Metabolic syndrome X

Indexed keywords

ADIPOCYTOKINE; C REACTIVE PROTEIN; CHOLESTEROL; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY FAT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; GENETIC ANALYSIS; GENETIC CORRELATION; HERITABILITY; HUMAN; HUMAN TISSUE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PARTICLE SIZE; PHENOTYPE; PRIORITY JOURNAL;

ADIPOSE TISSUE; ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERLIPIDEMIAS; METABOLIC SYNDROME X; MIDDLE AGED; PHENOTYPE; QUANTITATIVE TRAIT, HERITABLE;

EID: 40949107647     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.07.038     Document Type: Article

References (30)

1. Reaven G.M. Banting lecture: role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
2. Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287 (2002) 356-359
3. Lakka H.M., Laaksonen D.E., Lakka T.A., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288 (2002) 2709-2716
4. McNeill A.M., Rosamond W.D., Girman C.J., et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diab Care 28 (2005) 385-390
5. Laaksonen D.E., Lakka H.M., Niskanen L.K., et al. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 156 (2002) 1070-1077
6. Austin M.A., Edwards K.L., McNeely M.J., et al. Heritability of multivariate factors of the metabolic syndrome in nondiabetic Japanese-Americans. Diabetes 53 (2004) 1166-1169
7. Hanley A.J., Karter A.J., Festa A., et al. Factor analysis of metabolic syndrome using directly measured insulin sensitivity: The Insulin Resistance Atherosclerosis Study. Diabetes 51 (2002) 2642-2647
8. Kraja A.T., Hunt S.C., Pankow J.S., et al. An evaluation of the metabolic syndrome in the HyperGEN Study. Nutr Metab (Lond) 2 (2005) 2
9. Maison P., Byrne C.D., Hales C.N., Day N.E., and Wareham N.J. Do different dimensions of the metabolic syndrome change together over time? Evidence supporting obesity as the central feature. Diab Care 24 (2001) 1758-1763
10. Meigs J.B., D'Agostino Sr. R.B., Wilson P.W., et al. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes 46 (1997) 1594-1600
11. Sakkinen P.A., Wahl P., Cushman M., Lewis M.R., and Tracy R.P. Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am J Epidemiol 152 (2000) 897-907
12. Shen B.J., Todaro J.F., Niaura R., et al. Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome X. Am J Epidemiol 157 (2003) 701-711
13. Tang W., Miller M.B., Rich S.S., et al. Linkage analysis of a composite factor for the multiple metabolic syndrome: the National Heart, Lung, and Blood Institute Family Heart Study. Diabetes 52 (2003) 2840-2847
14. Arya R., Blangero J., Williams K., et al. Factors of insulin resistance syndrome-related phenotypes are linked to genetic locations on chromosomes 6 and 7 in nondiabetic Mexican-Americans. Diabetes 51 (2002) 841-847
15. Loos R.J., Katzmarzyk P.T., Rao D.C., et al. Genome-wide linkage scan for the metabolic syndrome in the HERITAGE Family Study. J Clin Endocrinol Metab 88 (2003) 5935-5943
16. Wyszynski D.F., Waterworth D.M., Barter P.J., et al. Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project). Am J Cardiol 95 (2005) 194-198
17. Hopper J.L., and Mathews J.D. Extensions to multivariate normal models for pedigree analysis. Ann Hum Genet 46 4 (1982) 373-383
18. Lange K., Westlake J., and Spence M.A. Extensions to pedigree analysis. III. Variance components by the scoring method. Ann Hum Genet 39 (1976) 485-491
19. Almasy L., and Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62 (1998) 1198-1211
20. Lange K., and Boehnke M. Extensions to pedigree analysis. IV. Covariance components models for multivariate traits. Am J Med Genet 14 (1983) 513-524
21. Mitchell B.D., Kammerer C.M., Mahaney M.C., et al. Genetic analysis of the IRS. Pleiotropic effects of genes influencing insulin levels on lipoprotein and obesity measures. Arterioscler Thromb Vasc Biol 16 (1996) 281-288
22. Barter P., McPherson Y.R., Song K., et al. Serum insulin and inflammatory markers in overweight individuals with and without dyslipidemia. J Clin Endocrinol Metab 92 (2007) 2041-2045
23. Cnop M., Havel P.J., Utzschneider K.M., et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46 (2003) 459-469
24. Cote M., Mauriege P., Bergeron J., et al. Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men. J Clin Endocrinol Metab 90 (2005) 1434-1439
25. Matsuzawa Y. Adipocytokines: emerging therapeutic targets. Curr Atheroscler Rep 7 (2005) 58-62
26. Hanley A.J., Festa A., D'Agostino Jr. R.B., et al. Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity. Diabetes 53 (2004) 1773-1781
27. Mohan V., Deepa R., Pradeepa R., et al. Association of low adiponectin levels with the metabolic syndrome-the Chennai Urban Rural Epidemiology Study (CURES-4). Metabolism 54 (2005) 476-481
28. Perusse L., Rice T., Despres J.P., et al. Familial resemblance of plasma lipids, lipoproteins and post-heparin lipoprotein and hepatic lipases in the HERITAGE Family Study. Arterioscler Thromb Vasc Biol 17 11 (1997) 3263-3269
29. Comuzzie A.G., Funahashi T., Sonnenberg G., et al. The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. J Clin Endocrinol Metab 86 (2001) 4321-4325
30. Pollin T.I., Tanner K., O'connell J.R., et al. Linkage of plasma adiponectin levels to 3q27 explained by association with variation in the APM1 gene. Diabetes 54 (2005) 268-274